GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Arich Enterprise Co Ltd (ROCO:4173) » Definitions » Forward PE Ratio

Arich Enterprise Co (ROCO:4173) Forward PE Ratio : 0.00 (As of Jun. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Arich Enterprise Co Forward PE Ratio?

Arich Enterprise Co's Forward PE Ratio for today is 0.00.

Arich Enterprise Co's PE Ratio without NRI for today is 20.63.

Arich Enterprise Co's PE Ratio for today is 20.52.


Arich Enterprise Co Forward PE Ratio Historical Data

The historical data trend for Arich Enterprise Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arich Enterprise Co Forward PE Ratio Chart

Arich Enterprise Co Annual Data
Trend
Forward PE Ratio

Arich Enterprise Co Quarterly Data
Forward PE Ratio

Competitive Comparison of Arich Enterprise Co's Forward PE Ratio

For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arich Enterprise Co's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Arich Enterprise Co's Forward PE Ratio falls into.



Arich Enterprise Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Arich Enterprise Co  (ROCO:4173) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Arich Enterprise Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Arich Enterprise Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Arich Enterprise Co (ROCO:4173) Business Description

Traded in Other Exchanges
N/A
Address
No.880, Zhongzheng Road, 14F-5, Zhonghe District, Taipei, TWN, 235601
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales and promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioner, and key accounts which includes chain stores and hyper markets, drug stores, and wholesalers. The product portfolio of the company includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.

Arich Enterprise Co (ROCO:4173) Headlines

No Headlines